News

UK: GlaxoSmithKline silent on talk of private equity swoop for Lucozade, Ribena

Most popular

Pernod is buying Malfy for the flavour - comment

The just-drinks Analyst returns

Is Carlsberg treating consumers like suckers

The just-drinks Analyst returns

Oddbins owner considers sale - just-drinks thinks

MORE

GlaxoSmithKline (GSK) has declined to comment on a report a US private equity firm is readying a bid for its Lucozade and Ribena brands.


Related Content

Suntory unveils Fruit Punch Lucozade Sport as UK boxer Anthony Joshua extends sponsorship deal

Suntory unveils Fruit Punch Lucozade Sport as UK boxer Anthony Joshua extends sponsorship deal...

Was Brown-Forman ever on the cards? The future of M&A for Constellation Brands - Analysis

Was Brown-Forman ever on the cards? The future of M&A for Constellation Brands - Analysis...

CHAMP finds a suitor for Accolade Wines as Carlyle talks come good

CHAMP finds a suitor for Accolade Wines as Carlyle talks come good...

This week in soft drinks & bottled water, featuring the vegan opportunity, Coca-Cola Co's Canadian asset sale and Lucozade comes out boxing

This week in soft drinks & bottled water, featuring the vegan opportunity, Coca-Cola Co's Canadian a...

Oops! This article is copy protected.

Why can’t I copy the text on this page?

The ability to copy articles is specially reserved for people who are part of a group membership.

How do I become a group member?

To find out how you and your team can copy and share articles and save money as part of a group membership call Sean Clinton on
+44 (0)1527 573 736 or complete this form..



Forgot your password?